Skip Ribbon Commands
Skip to main content
NL FR EN
Search

 Documentatie

 Documents

 Documentation

 

​Rapporten

​

​Artikels ​​

 ​

​Officiële documenten 

Resultaten over het gebruik en aanbod van illegale middelen tijdens de coronapandemie
Rapport [​NL]​ 


Factsheet Lachgas
Rapport [EN]​


Gender sensitieve preventie en hulpverlening
Naar gender-sensitieve preventie en hulpverlening voor vrouwelijke middelengebruikers in België 

 
Middelengebruik op muziekfestivals

 
Belgisch jaarrapport over Drugs: 
Nieuwe ontwikkelingen, trends en detail informatie
 
 
 
 

 
TDI
Rapport 2019 [​NL]​​​​

 
De​ indicator van behandelingsaanvragen betreffende drugs en alcohol in 2011-2014 in Brussels  [FR]​ en Wallonië 
[FR]
 

 
VAD  [NL]
 
 
 
Eurotox  [FR]
 
 
EMCDDA rapporten  [EN]
 
 
UNODC rapporten  [EN] 
 
 
 
 
 
 
WHO rapporten  [EN]

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 










 ​


​Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011-2014): a cross-sectional study​

2018 vol 76 no.17

 

 

Longitudinal pharmacoepidemiological and health services research for substance users in treatment: protocol of the Belgian TDI-IMA linkage​

2018 vol.76 no.3​

 

 
Identification of a new tert-leucinate class synthetic ​cannabinoid in powder and "spice-like" herbal incenses: 5F-MDMB-PICA

Forensic Sci Int 2017 Vol. 273 p. 45-52 


 
Alternatives to prison for drug offenders in Belgium

Lisbon Addictions 24-26/10/2017, Lisbon-Portugal

 

 
Registration of treatment demands for substance use disorders in Belgium

Lisbon Addictions​ 24-26/10/2017, Lisbon-Portugal​

A case of acute intoxication due to combined use of fentanyl and U-47700

Forensic Sci Int 2016 Vol. 266 p. 68-72


Treatment for substance use disorders: the Belgian Treatment Demand Indicator registration protocol

Archives of pub​lic health 2016 vol.74 no.27​

 
General practice patients treated for substance use problems. A cross-national surveillance study
Lisbon Addictions 24/09/2015, Lisbon-Portugal
 
 
Non-general practice versus general practice patients treated for substance use problems
Lisbon Addictions 23/09/2015, Lisbon-Portugal

 

Health care trajectories and medication consumption of substance users in treatment : linking TDI and IMA databases (Belgium) 

Symposium Methods in Epidemiology   17/09/2015, Leuven-Belgium​

 

Hepatitis virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention
PLoS One    2014    vol.9    no.7 e103345
 
  
4-methyl-amphetamine: a health threat for recreational amphetamine users
Journal of psychopharmacology 2013    vol.27    no.9    817-822
 
 
Improved Benchmark-multiplier method to estimate the prevalence of ever-injecting drug use in Belgium, 2000-10 
Archives of public health    2013 vol.71    no.
 










 

 

 

 

 

 

 
 ​ Een geïntegreerd drugsbeleid in België
Federale drugnota 2001  [FR] - [NL]
 
Gemeenschappelijke verklaring van de interministeriële conferentie 
Drugs 2010  [FR]​ - [NL]
 
 
Belgisch waarnemingscentrum voor drugs en drugverslaving (BMCDDA)
 
 
 
 
Europese drugsbeleid documenten 
 
 
 







































 

 

 

 

 

 

 
 

 

 

 

 

 


 

 
 
 
 

 
 

 
 

 
 

 

 

 
 
 
 
 
 


 

 

 
 

 
 

 

 

 

 

 

 

 

 
 


 


 


 


 


 

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

​​

​Rapports          
 Articles ​ ​ ​ Documents​​ officiels
Résultats sur l'usage et l'offre de substances illégales en période de pandémie du COVID-19
Rapport [FR]​​ ​


Factsheet protoxyde d'azote
Report [EN]​


 
Un traitement et une prévention sensible au genre
Vers un traitement et une prévention sensible au genre pour femmes toxicomanes et alcooliques en Belgique 
​
Usage de drogues en milieu festif

 

 
Rapport annuel belge sur les drogues: 
 
Nouveaux développements, tendances et information détaillée 
 
 
 
 
        Chapitres séparés:

 
TDI

Rapport 2019 [FR​]​ 
 
L'indicateur de demande de traitement lié à l'usage de drogues ou d'alcool en 2011-2014 en Bruxelles [FR]​​ et Wallonie [FR]​​
 
 
VAD  [NL]
 
 
  
Eurotox  [FR]
 
 
 
Rapport de l'EMCDDA [EN] ​

 
 
Rapports de l'UNODC  [EN] 
 
   
 
 
 
 

 
Rapport de WHO  [EN]
 

 




 

 

 

 

 

 

 

 

 

 

 

 

 

Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011-2014): a cross-sectional study​

2018 vol 76 no.17​


Longitudinal pharmacoepidemiological and health services research for substance users in treatment: protocol of the Belgian TDI-IMA linkage

2018 vol.76 no.3​​


Identification of a new tert-leucinate class synthetic cannabinoid in powder and "spice-like" herbal incenses: 5F-MDMB-PICA

Forensic Sci Int 2017 Vol. 273 p. 45-52 

Alternatives to prison for drug offenders in Belgium

Lisbon Addictions 24-26/10/2017, Lisbon-Portugal

 

 
Registration of treatment demands for substance use disorders in Belgium

Lisbon Addictions​ 24-26/10/2017, Lisbon-Portugal​

 

A case of acute intoxication due to combined use of fentanyl and U-47700

Forensic Sci Int 2016 Vol. 266 p. 68-72


Treatment for substance use disorders: the Belgian Treatment Demand Indicator registration protocol

Archives of pub​lic health 2016 vol.74 no.27

General practice patients treated for substance use problems. A cross-national surveillance study
Lisbon Addictions 24/09/2015, Lisbon-Portugal
 
 
Non-general practice versus general practice patients treated for substance use problems
Lisbon Addictions 23/09/2015, Lisbon-Portugal
 

Health care trajectories and medication consumption of substance users in treatment : linking TDI and IMA databases (Belgium) 

Symposium Methods in Epidemiology   17/09/2015, Leuven-Belgium​


Hepatitis V virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention
PLoS One    2014    vol.9    no.7 e103345
 
4-methyl-amphetamine: a health threat for recreational amphetamine users
Journal of psychopharmacology 2013  vol.27    no.9    817-822
 
Improved Benchmark-multiplier method to estimate the prevalence of ever-injecting drug use in Belgium, 2000-10 
Archives of public health    2013 vol.71    no.


 









 


 


 


 


 


 

 

 ​
Une politique intégrée en matière de drogues pour la Belgique
Note politique du Gouvernement fédéral relative à la problématique de la drogue 2001  [FR] - [NL]
 
Déclaration conjointe de la conférence Interministérielle Drogues  2010  [FR]​ - [NL]
 
 
l'Observatoire belge des drogues et des toxicomanies  (BMCDDA)
Déclaration de mission BMCDDA  [FR-NL]
 
La transmission d'informations au BMCDDA  [FR-NL]
 
Protocole enregistrement des demandes de traitement en matière de drogues et d'alcool  [FR-NL]
 
 
Documents de politique européenne en matière de drogue 
Stratégie européen sur les drogues 2013-2020 [EN]
 
Plan d'action européen sur les drogues 2013-2016 [EN]
 

 


 






 

 



























 

 

 

 

 

 

 

 

 

 

 

 

 

 
 
 

 

 

 

 



 

 

 

 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 

 
 
 
 
 

​

Reports   ​​
Articles ​ ​ ​ Official documents​​
Results on the use and supply of illicit substances during the coronapandemic
Report [NL]​ - [FR]​


Factsheet Nitrous oxide
Report [EN]​


Gender sensitive prevention and treatment
Towards gender-sensitive prevention and treatment for female substance users in Belgium 

 
​
Substance use at music festivals

 

 
Belgian Annual Report o​​n Drugs: 
New developments, trends and in-depth information  

 

 

 
       Seperate chapters:
 
TDI
 
Report 2019 [NL] - [F​R]​
 
The treatment demand indicator related to drugs and alcohol in 2011-2014 in Brussels [FR]​ and Wallonia [FR]

 
 
VAD  [NL]
 
 
Eurotox  [FR]
 
 
EMCDDA reports  [EN]
 
 
UNODC reports  [EN] 
 
 
 
 
 
 
WHO reports  [EN]



 







 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
































 

 

 

 

 

 

​


 


 

 

Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011-2014): a cross-sectional study​

2018 vol 76 no.17​

 

Longitudinal pharmacoepidemiological and health services research for substance users in treatment: protocol of the Belgian TDI-IMA linkage​

 
Archives of pub​lic health 2018 vol.76 no.3​

 

Identification of a new tert-leucinate class synthetic cannabinoid in powder and "spice-like" herbal incenses: 5F-MDMB-PICA

Forensic Sci Int 2017 Vol. 273 p. 45-52 


 
Alternatives to prison for drug offenders in Belgium

Lisbon Addictions 24-26/10/2017, Lisbon-Portugal

 

Registration of treatment demands for substance use disorders in Belgium

Lisbon Addictions​ 24-26/10/2017, Lisbon-Portugal

 

A case of acute intoxication due to combined use of fentanyl and U-47700

Forensic Sci Int 2016 Vol. 266 p. 68-72

 

Treatment for substance use disorders: the Belgian Treatment Demand Indicator registration protocol

Archives of pub​lic health 2016 vol.74 no.27


General practice patients treated for substance use problems. A cross-national surveillance study
Lisbon Addictions 24/09/2015, Lisbon-Portugal
 
 
Non-general practice versus general practice patients treated for substance use problems
Lisbon Addictions 23/09/2015, Lisbon-Portugal
 
 

Health care trajectories and medication consumption of substance users in treatment : linking TDI and IMA databases (Belgium) 

Symposium Methods in Epidemiology   17/09/2015, Leuven-Belgium​

 

Hepatitis V virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention

PLoS One    2014    vol.9    no.7 e103345

 

4-methyl-amphetamine: a health threat for recreational amphetamine users

Journal of psychopharmacology 2013    vol.27    no.9    817-822

 

Improved Benchmark-multiplier method to estimate the prevalence of ever-injecting drug use in Belgium, 2000-10 

Archives of public health    2013 vol.71    no.


 










 


 


 


 


 


 




 


 


 


 


 


 


 


 


 


 


 


 


 


 


 

 

 ​

 
An integrated drug policy in Belgium
 
Federal drugnote 2001  [FR] - [NL]
 
Joined Declaration by the Interministerial Drug Conference 2010  [FR]​ - [NL]
 
 
Belgian Monitoring Centre for Drugs and Drug Addiction (BMCDDA)
 
 
 
 
European drug policy documents
 

 

 

 



 















 

 

 

 

 

 

 
 

 

 

 

 

 

 

 

 

 

 

 
  

 

 

 

 

 

 

 


 








 


 


 

 


 


 


 


 


 


 

 


 


 


 


 


 

 

 

 

 


 

 

 

 

 
 
 
 
 
 
 
 

 

 
 
 
 
 
 
 
 
​